58 related articles for article (PubMed ID: 6151361)
41. Pharmacokinetics of 3-[bis(2-hydroxyethyl)amino]acetophenone-(4,5-diphenyloxazol-2-yl) hydrazone (ZIMET 98/69) after oral administration to mice.
Amlacher R; Ulbricht H
Pharmazie; 1985 May; 40(5):338-40. PubMed ID: 2863831
[TBL] [Abstract][Full Text] [Related]
42. Pharmacokinetics of 3-[bis(2-hydroxyethyl)amino]acetophenone [4,5-diphenyloxazolyl-(2)]hydrazone (ZIMET 98/69) in rats.
Amlacher R; Horn U; Kramarczyk K; Ulbricht H; Hoffmann H
Pharmazie; 1982 Jan; 37(1):33-5. PubMed ID: 6122223
[TBL] [Abstract][Full Text] [Related]
43. Sex- and age-related mouse toxicity and disposition of the amino acid antitumor agent, acivicin.
McGovren JP; Neil GL; Chan PJ; Stewart JC
J Pharmacol Exp Ther; 1981 Mar; 216(3):433-40. PubMed ID: 7205622
[TBL] [Abstract][Full Text] [Related]
44. The immunosuppressive effect of beta-[1-phenyl-5-bis(beta-chloroethyl)-aminobenzimidazolyl-(2)]-DL-alanine (ZIMET 3164) on cell-mediated immunity in mice.
Heinecke H; Ozegowski W
Allerg Immunol (Leipz); 1980; 26(1):41-5. PubMed ID: 6447447
[TBL] [Abstract][Full Text] [Related]
45. Pharmacokinetics of muraglitazar (BMS-298585), a dual peroxisome proliferator-activated receptors (PPAR) alpha and gamma activator, in mice, rats, dogs, and monkeys.
Hosagrahara VP; Chandrasena G; Chang SY; Koplowitz B; Hariharan N; Cheng PT; Humphreys WG
Xenobiotica; 2006 Dec; 36(12):1227-38. PubMed ID: 17162469
[TBL] [Abstract][Full Text] [Related]
46. Pharmacokinetics of 3-[Bis(2-hydroxyethyl)amino]acetophenone-(4,5- diphenyloxazol-2-yl)hydrazone (ZIMET 98/69) in mice.
Amlacher R; Ulbricht H
Acta Virol; 1984 Sep; 28(5):445. PubMed ID: 6151361
[No Abstract] [Full Text] [Related]
47. Use of pharmacokinetics in veterinary medicine. Article. II: Volume, clearance, and half-life.
Martinez MN
J Am Vet Med Assoc; 1998 Oct; 213(8):1122-7. PubMed ID: 9787378
[No Abstract] [Full Text] [Related]
48. [Advances and related issues in the use of in vitro methods to predict metabolic clearance rate of new drugs].
Zhang Q; Wang GJ
Yao Xue Xue Bao; 2007 Oct; 42(10):1023-8. PubMed ID: 18229605
[TBL] [Abstract][Full Text] [Related]
49. Prediction of human pharmacokinetics - renal metabolic and excretion clearance.
Fagerholm U
J Pharm Pharmacol; 2007 Nov; 59(11):1463-71. PubMed ID: 17976256
[TBL] [Abstract][Full Text] [Related]
50.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
51.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
52.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
53.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
